HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markus Mitterhauser Selected Research

melanin-concentrating hormone receptor

1/2019SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18F]FE@SNAP and [11C]SNAP-7941.
12/2016[(18)F]FE@SNAP-a specific PET tracer for melanin-concentrating hormone receptor 1 imaging?
10/2013Preclinical in vitro &in vivo evaluation of [(11)C]SNAP-7941 - the first PET tracer for the melanin concentrating hormone receptor 1.
10/2012[¹⁸F]FE@SNAP-A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markus Mitterhauser Research Topics

Disease

28Neoplasms (Cancer)
02/2022 - 03/2005
15Prostatic Neoplasms (Prostate Cancer)
06/2022 - 06/2006
8Inflammation (Inflammations)
11/2021 - 01/2008
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 02/2013
7Neoplasm Metastasis (Metastasis)
01/2021 - 08/2006
7Mood Disorders (Mood Disorder)
01/2019 - 01/2008
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2012
4Obesity
01/2019 - 10/2012
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 12/2014
4Anxiety Disorders (Anxiety Disorder)
10/2015 - 10/2010
3Atherosclerosis
11/2021 - 01/2017
3Glioma (Gliomas)
06/2021 - 01/2018
3Breast Neoplasms (Breast Cancer)
01/2019 - 11/2003
3Major Depressive Disorder (Major Depressive Disorders)
01/2018 - 11/2012
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 01/2016
2Lymphoma (Lymphomas)
11/2021 - 01/2019
2Treatment-Resistant Depressive Disorder
09/2020 - 05/2019
2Epilepsy (Aura)
01/2020 - 10/2014
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2020
2Arthritis (Polyarthritis)
01/2019 - 05/2015
2Atherosclerotic Plaque (Atheroma)
01/2018 - 07/2016
2Asthma (Bronchial Asthma)
05/2015 - 04/2015
2Glaucoma
05/2015 - 04/2015
2Temporal Lobe Epilepsy
10/2014 - 11/2010
2Portal Hypertension
06/2014 - 04/2013
2Social Phobia
10/2010 - 05/2007
2Infections
02/2005 - 10/2004
1Residual Neoplasm
06/2022
1Arteritis
11/2021
1Anemia
05/2021
1Thrombocytopenia (Thrombopenia)
05/2021
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Schizophrenia (Dementia Praecox)
01/2020

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
02/2022 - 06/2014
85-HT1A Serotonin ReceptorIBA
01/2019 - 05/2007
6LigandsIBA
06/2022 - 12/2018
6Proteins (Proteins, Gene)FDA Link
08/2021 - 08/2013
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2021 - 01/2016
5Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
03/2016 - 02/2013
4Amino AcidsFDA Link
06/2021 - 03/2005
4Pharmaceutical PreparationsIBA
01/2021 - 07/2014
4Monoamine Oxidase (MAO)IBA
09/2020 - 09/2014
4melanin-concentrating hormone receptorIBA
01/2019 - 10/2012
4Acetates (Acetic Acid Esters)FDA Link
11/2018 - 11/2015
3AntigensIBA
06/2022 - 06/2021
3Antidepressive Agents (Antidepressants)IBA
01/2022 - 11/2014
3Methionine (L-Methionine)FDA Link
06/2021 - 03/2005
3177Lu-PSMA-617IBA
01/2021 - 05/2019
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019 - 08/2013
3fluoromisonidazoleIBA
01/2018 - 01/2016
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2021 - 01/2018
2RadiopharmaceuticalsIBA
06/2020 - 03/2005
2Dopamine (Intropin)FDA LinkGeneric
01/2020 - 11/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2020
2FluoridesIBA
04/2019 - 01/2019
268Ga-pentixaforIBA
01/2019 - 01/2018
2Chemokine ReceptorsIBA
01/2019 - 01/2018
2Fatty Acid Synthases (Fatty Acid Synthase)IBA
11/2018 - 11/2015
2Radium-223IBA
01/2018 - 09/2016
2Prostate-Specific Antigen (Semenogelase)IBA
12/2015 - 06/2006
2Neurotransmitter Agents (Neurotransmitter)IBA
08/2014 - 07/2014
2Serotonin (5 Hydroxytryptamine)IBA
07/2014 - 11/2010
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
11/2010 - 10/2010
2Ciprofloxacin (Cipro)FDA LinkGeneric
02/2005 - 10/2004
1GalliumIBA
06/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022
1KetamineFDA LinkGeneric
01/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1Phosphates (Orthophosphate)IBA
09/2021
1ParaffinIBA
06/2021
1Hemoglobins (Hemoglobin)IBA
05/2021
1AndrogensIBA
01/2021
1Docetaxel (Taxotere)FDA Link
01/2021
1PSMA-617IBA
01/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1enzalutamideIBA
01/2021
1Crystallins (Crystallin)IBA
01/2021
1abirateroneIBA
01/2021
1cabazitaxelFDA Link
01/2021
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2020
1Sorbitol (Yal)FDA Link
06/2020
1BombesinIBA
06/2020
1CarbohydratesIBA
06/2020
1BilirubinIBA
01/2020
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2020
1SodiumIBA
01/2020
1Amphetamine (Amfetamine)FDA LinkGeneric
01/2020
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2020
1LipidsIBA
01/2020
1naxagolideIBA
01/2020
1Blood Glucose (Blood Sugar)IBA
01/2020
1PSMA-11IBA
09/2019
1Harmine (Telepathine)IBA
05/2019

Therapy/Procedure

24Therapeutics
06/2022 - 11/2003
9Castration
01/2022 - 01/2018
3Radiotherapy
01/2019 - 01/2016
2Pancreaticoduodenectomy
09/2020 - 03/2017
1Cytoreduction Surgical Procedures
06/2022
1Immunotherapy
11/2021
1Intravenous Administration
01/2021